|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,080.00 KRW | -2.68% |
|
+7.40% | -25.51% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.68% | +7.40% | -42.08% | - | 82.27M | ||
| -1.02% | -3.46% | +85.72% | +459.93% | 37.52B | ||
| +1.98% | +4.73% | +10.86% | +35.62% | 24.34B | ||
| +2.02% | -3.02% | -25.07% | -40.23% | 7.33B | ||
| +0.97% | -1.00% | +9.97% | +78.62% | 4.84B | ||
| +4.27% | +4.26% | +13.76% | +49.95% | 3.05B | ||
| -6.75% | -6.90% | -27.44% | +659.64% | 1.75B | ||
| -2.46% | -4.93% | +116.36% | -16.88% | 1.81B | ||
| -2.07% | -1.52% | -14.82% | -63.83% | 1.78B | ||
| +5.58% | -1.99% | +14.91% | +3.77% | 1.74B | ||
| Average | -0.02% | -0.78% | +14.22% | +129.62% | 8.42B | |
| Weighted average by Cap. | +0.38% | -0.68% | +42.09% | +230.28% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















